A Phase II Study: Paclitaxel and Pelvic Radiation for Stage I-IIIA Papillary Serous Carcinoma of the Endometrium.
Phase of Trial: Phase II
Latest Information Update: 06 May 2013
At a glance
- Drugs Paclitaxel (Primary)
- Indications Endometrial cancer
- Focus Adverse reactions; Therapeutic Use
- 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jan 2013 Planned end date changed from 1 Apr 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.
- 17 Jan 2012 Planned end date changed from 1 Apr 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.